Science Spotlight on Cerebral Palsy and Genetics: Cerebral Palsy Genetic Research Findings, Part Three

Fri 24 Mar 2023

Science Spotlight: Cerebral Palsy and Genetics
Part Three: Cerebral Palsy Genetic Research Findings

By Dr. Sara Lewis

Catch up on the first two parts of this blog series, which covered genetics concepts and methods for finding genetic causes for cerebral palsy. 

Peer-reviewed reports on cerebral palsy (CP) genetics are increasing every year, with over 1500 publications to date. There have been several studies on groups of people with CP using whole exome sequencing (WES) from all around the world. It’s now possible to do meta-analyses — synthesizing these findings using statistics to answer important questions. A meta-analysis conducted by Dr. Srivastava and others used 11 studies of almost 2,500 patients to determine what fraction of CP is due to genetic causes and which genes may be responsible.

To answer what percentage of people may have a genetic explanation for their CP, the meta-analysis looked at the proportion of individuals who had a pathogenic variant — a mutation that was predicted to be the cause of the person’s CP.

Overall, this analysis predicts an average of 23% of people with CP have a genetic cause that can be found via WES. Digging deeper, patients with CP who have no risk factor have a 35% likelihood of having a genetic cause. Patients with a risk factor, such as premature birth, have a 7% likelihood of having a genetic cause. The meta-analysis also assessed chromosomal microarray, where sequences of DNA bind to probes to quantify the relative amount of DNA in different parts of the genome. Microarray is used to detect copy number variants, such as deletions or duplications; an estimated 5% of individuals have a deletion or duplication that may be contributing to their cerebral palsy.

Srivastava et al. reported genes with one or more pathogenic variants found in patients with CP. There were 258 genes identified, but few of these genes were recurrent or had more than one individual described with variants. Therefore, variants that cause CP are individually rare for each gene, but collectively common across all genes. Of note, these genes have often been previously linked to neurodevelopmental disabilities, such as intellectual disability, autism, and epilepsy.

In addition to 258 genes described as having pathogenic variants in individuals with cerebral palsy, there are now more than 1,000 potential candidate genes. Some of these genes appear to be a likely genetic explanation for some cases of CP based on laboratory research on gene function, but it can sometimes be difficult to say, “yes, this is it!” without knowing about similar findings in multiple patients.

In summary, the range of genetic contributions to cerebral palsy is 7 – 35%. In comparison, estimated genetic contributions to cerebral palsy based on familial rates and other epidemiology methods is ~40%. Therefore, genetic variants can be a contributing factor for developing CP and many more genes await discovery. The gap between observed and predicted genetic contributions may be due to more complex inheritance, such as polygenic or gene-environment interactions. Currently available techniques are not able to study these genetic contributions in detail but may be able to understand complex genetic factors of CP in the future.


About the Author: Dr. Sara Lewis is a Postdoctoral Research Associate at Phoenix Children’s Hospital working with Dr. Michael Kruer to identify genetic causes of cerebral palsy. She received her PhD in Neuroscience in 2015 with an emphasis in genetic neurodevelopmental disorders. Her work integrates human genetics with the fly model to study how genes leading to movement disorders changes in the brain. Her work also addresses the challenges implementing genetics findings in the clinical environment. Her research is funded by CPARF.

Article cited: Srivastava S, Lewis SA, Cohen JS, Zhang B, Aravamuthan BR, Chopra M, Sahin M, Kruer MC, Poduri A. Molecular Diagnostic Yield of Exome Sequencing and Chromosomal Microarray in Cerebral Palsy: A Systematic Review and Meta-analysis. JAMA Neurol. 2022 Dec 1;79(12):1287-1295. doi: 10.1001/jamaneurol.2022.3549. PMID: 36279113; PMCID: PMC9593320.

https://jamanetwork.com/journals/jamaneurology/article-abstract/2797273

Wed 21 May 2025

Bold graphic promoting STEPtember 2025. The word “STEPtember” is displayed prominently in large, stylized text on a dark blue background. Below it reads “2025 Challenge is Coming Soon,” framed by green dotted arrow graphics pointing inward. The logo for the Cerebral Palsy Alliance Research Foundation is displayed in the bottom right corner on a bright teal strip.

Are you ready for STEPtember 2025? We’re officially in double digits — CPARF is celebrating 10 years of funding groundbreaking cerebral palsy research and driving innovation forward. And there’s no better way to mark this milestone than with our biggest, boldest STEPtember yet. Thanks to you, STEPtember has grown into a global movement that powers […]

Thu 15 May 2025

Illustration promoting birthday fundraisers for the Cerebral Palsy Alliance Research Foundation. The left side features a green box with the message “Celebrate Your Birthday with Purpose” and the CPARF logo. The background is a cheerful pattern of cakes, balloons, and presents. On the right, a photo shows a joyful group of people, including children and adults, throwing confetti around a birthday cake. The bottom of the photo reads “Happy Birthday!” in playful blue script.

Celebrate Your Birthday with Purpose: Start a Fundraiser That Changes Lives Birthdays are for joy, reflection, and connection — and now, they can help fund groundbreaking research, fuel innovation in assistive technology, and create lasting change for people with cerebral palsy and other disabilities. Celebrate your special day by starting a customized birthday fundraiser to […]